Erik Hett

Erik Hett serves as Chief Technology Officer at Sonata Therapeutics since March 2022 and is an Advisory Board Member for both Bunker Hill Community College's Division of Workforce & Economic Development and Tufts University since January 2020 and August 2019, respectively. Prior experience includes leadership roles at Merck as Senior Director and Director of Experimental and Chemical Biology and leading teams at Biogen and Pfizer. Erik's research background includes a Postdoctoral Fellowship at Massachusetts General Hospital and multiple affiliations with Harvards institutions. Educational qualifications include a PhD in Immunology and Infectious Diseases from Harvard, an MPH from Yale, and a B.S. from Montana State University-Bozeman, complemented by a certificate in Disruptive Strategy from Harvard Business School Online.